New York State Common Retirement Fund Graybug Vision, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.18 - $5.17 $209 - $341	-66 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.53 - $6.1 $20,421 - $35,288	-5,785 Reduced 98.87%	66 $0
Q1 2021 May 11, 2021	BUY	$5.55 - $35.0 $11,938 - $75,285	2,151 Added 58.14%	5,851 $32,000
Q4 2020 Feb 08, 2021	BUY	$13.05 - $33.93 $48,285 - $125,541	3,700 New	3,700 $107,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.